Skip to content
Catalyst

fucoxanthinSources cited

  1. Consumption of Low Dose Fucoxanthin Does Not Prevent Hepatic and Adipose Inflammation and Fibrosis in Mouse Models of Diet-Induced Obesity.2022animalPMID:356840791 finding
  2. Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway.2022in vitroPMID:354478991 finding
  3. Fucoxanthin Prevents 6-OHDA-Induced Neurotoxicity by Targeting Keap1.2021in vitroPMID:337773211 finding
  4. Fucoxanthin rescues dexamethasone induced C2C12 myotubes atrophy.2021in vitroPMID:338650171 finding
  5. Fucoxanthin Suppresses Osteoclastogenesis via Modulation of MAP Kinase and Nrf2 Signaling.2021in vitroPMID:336737041 finding
  6. Anti-Obesity Effect of Standardized Extract of Microalga Phaeodactylum tricornutum Containing Fucoxanthin.2019animalPMID:311379221 finding